TY - JOUR
KW - Adult
KW - Age Factors
KW - Aged
KW - Diabetes Mellitus, Type 2/drug therapy
KW - Diabetic Ketoacidosis/*chemically induced
KW - Dipeptidyl-Peptidase IV Inhibitors/adverse effects/therapeutic use
KW - Female
KW - Humans
KW - Hypoglycemic Agents/*adverse effects/therapeutic use
KW - Male
KW - Middle Aged
KW - propensity score
KW - Proportional Hazards Models
KW - Retrospective Studies
KW - Risk Factors
KW - Sex Factors
KW - Sodium-Glucose Transporter 2 Inhibitors/*adverse effects/therapeutic use
KW - Young Adult
AU - A. Douros
AU - L. Lix
AU - M. Fralick
AU - S. Dell'Aniello
AU - B. Shah
AU - P. Ronksley
AU - É Tremblay
AU - N. Hu
AU - S. Alessi-Severini
AU - A. Fisher
AU - S. Bugden
AU - P. Ernst
AU - K. Filion
AD - McGill University and Centre for Clinical Epidemiology, Lady Davis Institute, Montreal, Quebec, Canada, and Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Berlin, Germany (A.D.).
University of Manitoba, Winnipeg, Manitoba, Canada (L.M.L.).
Sinai Health System and University of Toronto, Toronto, Ontario, Canada (M.F.).
Centre for Clinical Epidemiology, Lady Davis Institute, Montreal, Quebec, Canada (S.D.).
University of Toronto, ICES, and Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (B.R.S.).
Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada (P.E.R.).
Institut national d'excellence en santé et en services sociaux (INESSS), Quebec City, Quebec, Canada (É.T.).
The Health Quality Council, Saskatoon, Saskatchewan, Canada (N.H.).
College of Pharmacy and Manitoba Centre for Health Policy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada (S.A.).
University of British Columbia, Vancouver, British Columbia, Canada (A.F.).
College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada, and School of Pharmacy, Memorial University of Newfoundland, St John's, Newfoundland and Labrador, Canada (S.C.B.).
McGill University and Centre for Clinical Epidemiology, Lady Davis Institute, Montreal, Quebec, Canada (P.E., K.B.F.).
AN - 32716707
BT - Ann Intern Med
DO - 10.7326/m20-0289
DP - NLM
ET - 2020/07/28
LA - eng
M1 - 6
N1 - 1539-3704
Douros, Antonios
Orcid: 0000-0002-6005-4006
Lix, Lisa M
Fralick, Michael
Dell'Aniello, Sophie
Shah, Baiju R
Orcid: 0000-0003-3598-3628
Ronksley, Paul E
Tremblay, Éric
Hu, Nianping
Alessi-Severini, Silvia
Fisher, Anat
Orcid: 0000-0001-9730-5107
Bugden, Shawn C
Ernst, Pierre
Orcid: 0000-0001-9983-3608
Filion, Kristian B
Canadian Network for Observational Drug Effect Studies (CNODES) Investigators
DSE-146021/CIHR/Canada
Comparative Study
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
United States
Ann Intern Med. 2020 Sep 15;173(6):417-425. doi: 10.7326/M20-0289. Epub 2020 Jul 28.
PY - 2020
SN - 0003-4819
SP - 417
EP - 425
T2 - Ann Intern Med
TI - Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study
VL - 173
ER -